Carnegie acted as financial adviser in the directed new share in Hansa Medical. Hansa Medical is a biopharmaceutical company focused on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant rejection.October 2016.
Healthcare
Directed new share issue in Hansa Medical AB (SE) — SEK 185 million
October 2016